Blood Plasma Market Size, Share, Analysis Report

Blood Plasma Market By Product (Immunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates); By Application (Hospitals and Clinics, Research Laboratories, Academic Institutions) and by Regional Analysis - Global Forecast by

The Blood Plasma Market is expected to be around US$ 62 Billion by 2028 at a CAGR of 9% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Baxter International
  • CSL
  • Grifols
  • Octapharma
  • ADMA Biologics
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    9

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Plasma is the fluid part of the blood. Plasma is the flexible part and makes around 55% of the blood. Plasma is the composite blend of in excess of 700 proteins and different substances which are fundamental for the proficient working of the human body. Plasma helps in controlling body temperature and pulse. It fills in as a medium for trade of proteins, supplements and hormones to the diverse parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma.

    How Big is The Blood Plasma Market?

    The Blood Plasma Market is expected to be around US$ 62 Billion by 2028 at a CAGR of 9% in the given forecast period.

    The major driving factors of Blood Plasma Market are as follows:

    • Government and private organization support blood donation camps and programs to meet the rising demand of plasma
    • Rise in prevalence of bleeding disorders
    • Increasing kidney disorder that requires blood plasma product as a therapeutic

    The major restraining factors of Blood Plasma Market are as follows:

    • Stringent regulatory standards on the import and export of plasma product
    • High complexity and cost associated with the collection of blood plasma
    • Dearth of skilled and trained professionals for fractionation procedure

    The major opportunities of Blood Plasma Market are as follows:

    • Identification of new proteins in blood plasma to be used as therapeutic products are under clinical investigation
    • Exploring novel therapeutic application of the known blood plasma product to be used for other diseases

    The Blood Plasma Market has been segmented as below:

    By Product:

    • Immunoglobulin
    • Albumin
    • Protease Inhibitors
    • Coagulation Factor Concentrates
    • Others

    By Application:

    • Hospitals and Clinics
    • Research Laboratories
    • Academic Institutions

    The Blood Plasma Market is segmented on the lines of its product, application and regional. On the basis of product segmentation, it covers Immunoglobulin, Albumin, Protease Inhibitors, Coagulation factor concentrates and others. Based on application it is classified as Hospitals and clinics, Research Laboratories and Academic Institutions. The Blood Plasma Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:

    1) An overview of the global market for Blood Plasma Market and related technologies.
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for Blood Plasma Market

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry. 

    Report scope:

    The scope of the report includes a detailed study of Blood Plasma Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas and TCS Biosciences. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    Reasons to Buy this Report:

    1. Obtain the most up to date information available on all Blood Plasma Market.
    2. Identify growth segments and opportunities in the industry.
    3. Facilitate decision making on the basis of strong historic and forecast of Blood Plasma Market.
    4. Assess your competitor’s refining portfolio and its evolution.

    Customization:

    We can offer you custom research reports as per client’s special requirements.

    Below are our New Reports :-

    Foot and Mouth Disease (FMD) Vaccine Market

    Flow Cytometry Market

    Fetal bovine serum Market

    Medicated Feed Additives Market

    Orally Disintegrating Tablet (ODT) market

    1.    Introduction
        1.1    Report Description
        1.2    Markets Covered
        1.3    Stakeholders

    2.    Research Methodology
        2.1    Research Data
        2.2    Market Size Estimation and Data Triangulation
        2.3    Research Assumptions

    3.    Report Summary

    4.    Market Overview
        4.1    Introduction
        4.2    Drivers
        4.3    Restrains
        4.4    Industry Trends
        4.5    Porter’s Five Forces Analysis

    5.    Blood Plasma Market  Analysis, By Product
        5.1    Immunoglobulin
        5.2    Albumin
        5.3    Protease Inhibitors
        5.4    Coagulation Factor Concentrates
        5.5    Others

    6.    Blood Plasma Market  Analysis, By Application
        6.1    Hospitals and Clinics
        6.2    Research Laboratories
        6.3    Academic Institutions

    7.    Blood Plasma Market  Analysis, By Region
        7.1    North America
        7.2    Europe
        7.3    Asia-Pacific
        7.4    Rest of the World

    8.    Competitive Overview
        8.1    Introduction
        8.2    New Product Launches
        8.3    Acquisitions
        8.4    Agreements, Partnerships, And Collaborations
        8.5    Expansions

    9.    Company Profiles
        9.1    Baxter International
        9.2    CSL
        9.3    Grifols
        9.4    Octapharma
        9.5    ADMA Biologics
        9.6    Cerus Corp
        9.7    Sanquin
        9.8    Shanghai Raas
        9.9    TCS Biosciences

    The Blood Plasma Market has been segmented as below:

    By Product:

    • Immunoglobulin
    • Albumin
    • Protease Inhibitors
    • Coagulation Factor Concentrates
    • Others

    By Application:

    • Hospitals and Clinics
    • Research Laboratories
    • Academic Institutions

    By Regional Analysis:

    •     North America
    •     Europe
    •     Asia-Pacific
    •     Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 9% during the study period (2023-2028)
    The Blood Plasma Market is expected to be around US$ 62 Billion by 2028
    The segment included in the Blood Plasma Market is Product, Application and region.
    Some key players operating in the Blood Plasma Market include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas and TCS Biosciences
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports